NCT02173964 Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose) Status COMPLETED Phase PHASE4
NCT02173756 Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults Status TERMINATED Phase PHASE3
NCT02159482 Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines Status TERMINATED Phase PHASE2
NCT02158637 Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Status COMPLETED Phase N/A
NCT02157519 Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer Status COMPLETED Phase NA
NCT02154022 Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity Status ENROLLING_BY_INVITATION Phase N/A
NCT02151357 Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor Status TERMINATED Phase PHASE1
NCT02150733 Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment Status COMPLETED Phase PHASE1
NCT02150148 Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors Status COMPLETED Phase NA
NCT02138448 Implementing Personal Health Records to Promote Evidence-Based Cancer Screening Status COMPLETED Phase NA
NCT02137954 Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study. Status UNKNOWN Phase PHASE3
NCT02137811 Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo) Status WITHDRAWN Phase N/A
NCT02134340 A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours Status COMPLETED Phase PHASE1
NCT02124772 Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations Status COMPLETED Phase PHASE1/PHASE2
NCT02121626 The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms" Status COMPLETED Phase N/A
NCT02112461 Hospice and End-of-life Symptom Monitoring & Support Using an Automated System Designed for Family Caregivers Status COMPLETED Phase NA